![](/img/cover-not-exists.png)
PCN69 COST-EFFECTIVENESS ANALYSIS OF DASATINIB 100 MG VS. IMATINIB 800 MG IN PATIENTS WITH IMATINIB-RESISTANT CHRONIC MYELOID LEUKEMIA IN SPAIN
de Ramirez, A Arellano, U Sbarigia, MJ Taylor, P Martin, G RestovicVolume:
13
Year:
2010
Language:
english
DOI:
10.1016/s1098-3015(11)71964-7
File:
PDF, 76 KB
english, 2010